永安药业
(002365)
| 流通市值：26.91亿 | | | 总市值：32.33亿 |
| 流通股本：2.45亿 | | | 总股本：2.95亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 253,213,751.54 | 230,585,726.41 | 234,835,187.73 | 267,439,688.6 |
| 交易性金融资产 | 622,768,814.05 | 687,885,327.94 | 687,313,267.01 | 663,569,139.75 |
| 应收票据及应收账款 | 154,888,162.49 | 122,816,396.29 | 134,815,540.67 | 127,341,534.62 |
| 其中：应收票据 | 1,300,077.97 | 5,980,717.37 | 10,316,592.96 | 14,812,468.14 |
| 应收账款 | 153,588,084.52 | 116,835,678.92 | 124,498,947.71 | 112,529,066.48 |
| 应收款项融资 | 7,958,428.98 | 2,152,013.64 | 4,113,500 | 250,000 |
| 预付款项 | 12,850,450.83 | 8,813,805.83 | 18,466,559.45 | 7,326,551.77 |
| 其他应收款合计 | 3,110,307.06 | 5,437,851.15 | 5,227,998.79 | 4,684,714.92 |
| 存货 | 78,974,280.04 | 90,892,788.12 | 78,413,956.41 | 100,619,312.68 |
| 其他流动资产 | 5,350,789.42 | 4,157,842.55 | 4,461,772.08 | 5,659,190.55 |
| 流动资产合计 | 1,139,114,984.41 | 1,152,741,751.93 | 1,167,647,782.14 | 1,176,890,132.89 |
| 非流动资产: | | | | |
| 长期股权投资 | 75,297,866.25 | 74,455,305.7 | 77,889,400.19 | 76,482,646.09 |
| 固定资产 | 835,543,566.9 | 859,783,604.44 | 898,275,188.84 | 902,878,924.94 |
| 在建工程 | 53,724,370.57 | 18,900,382.64 | 10,857,183.47 | 17,613,475.71 |
| 无形资产 | 75,959,914.32 | 76,821,891.9 | 77,728,091.22 | 78,596,442.57 |
| 递延所得税资产 | 11,860,831.85 | 11,410,902.47 | 8,844,564.9 | 7,603,299.38 |
| 其他非流动资产 | 3,717,269.8 | 6,547,752.02 | 21,188,663.08 | 6,521,652.9 |
| 非流动资产合计 | 1,056,103,819.69 | 1,047,919,839.17 | 1,094,783,091.7 | 1,089,696,441.59 |
| 资产总计 | 2,195,218,804.1 | 2,200,661,591.1 | 2,262,430,873.84 | 2,266,586,574.48 |
| 流动负债: | | | | |
| 短期借款 | 745,182.07 | 750,000 | 28,372,624.17 | 33,526,895.84 |
| 应付票据及应付账款 | 113,501,958.35 | 115,570,758.96 | 121,260,957.79 | 112,610,174.46 |
| 应付账款 | 113,501,958.35 | 115,570,758.96 | 121,260,957.79 | 112,610,174.46 |
| 合同负债 | 25,157,472.07 | 20,095,306.72 | 22,976,074.75 | 15,520,918.13 |
| 应付职工薪酬 | 26,158,625.23 | 36,103,443.98 | 31,933,224.23 | 27,204,352.52 |
| 应交税费 | 12,644,170.15 | 12,323,913.03 | 7,274,475.21 | 5,767,905.18 |
| 其他应付款合计 | 7,494,604.22 | 7,508,018.13 | 7,264,185.59 | 36,282,661.82 |
| 应付股利 | - | - | - | 28,914,515 |
| 其他流动负债 | 5,654,234.52 | 11,583,781.54 | 13,350,521.3 | 13,579,862.95 |
| 流动负债合计 | 191,356,246.61 | 203,935,222.36 | 232,432,063.04 | 244,492,770.9 |
| 非流动负债: | | | | |
| 递延收益 | 8,796,984.34 | 9,284,960.53 | 6,074,971.27 | 6,535,718.32 |
| 递延所得税负债 | 4,354,777.22 | 5,501,770.17 | 8,692,779.63 | 9,272,736.3 |
| 非流动负债合计 | 13,151,761.56 | 14,786,730.7 | 14,767,750.9 | 15,808,454.62 |
| 负债合计 | 204,508,008.17 | 218,721,953.06 | 247,199,813.94 | 260,301,225.52 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 294,682,500 | 294,682,500 | 294,682,500 | 294,682,500 |
| 资本公积 | 722,296,494.36 | 722,296,494.36 | 714,504,838.03 | 714,504,838.03 |
| 减:库存股 | 40,475,988.99 | 40,475,988.99 | 40,475,988.99 | 40,475,988.99 |
| 其他综合收益 | 2,116,624.31 | 2,231,518.43 | 2,314,983.54 | 2,370,011 |
| 专项储备 | 29,686,975.72 | 28,789,636.43 | 22,918,723.57 | 21,677,035.3 |
| 盈余公积 | 148,676,496.29 | 148,676,496.29 | 148,676,496.29 | 148,676,496.29 |
| 未分配利润 | 838,544,341.3 | 830,807,637.84 | 833,810,467.48 | 820,809,931.64 |
| 归属于母公司股东权益合计 | 1,995,527,442.99 | 1,987,008,294.36 | 1,976,432,019.92 | 1,962,244,823.27 |
| 少数股东权益 | -4,816,647.06 | -5,068,656.32 | 38,799,039.98 | 44,040,525.69 |
| 股东权益合计 | 1,990,710,795.93 | 1,981,939,638.04 | 2,015,231,059.9 | 2,006,285,348.96 |
| 负债和股东权益合计 | 2,195,218,804.1 | 2,200,661,591.1 | 2,262,430,873.84 | 2,266,586,574.48 |
| 公告日期 | 2026-04-30 | 2026-04-17 | 2025-10-30 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |